Details for New Drug Application (NDA): 215362
✉ Email this page to a colleague
NDA 215362 describes BUMETANIDE, which is a drug marketed by Anthea Pharma, Aspiro, Gland, Hospira, Lupin Ltd, MSN, Qilu Pharm Hainan, Sagent, Teva Parenteral, West-ward Pharms Int, Amneal Pharms Co, Appco, Heritage Pharma, Jubilant Generics, Mankind Pharma, Rising, Rubicon Research, Sandoz, Taro, Upsher Smith Labs, and Zydus Pharms, and is included in twenty-three NDAs. It is available from thirty-six suppliers. Additional details are available on the BUMETANIDE profile page.
The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 215362
| Tradename: | BUMETANIDE |
| Applicant: | Msn |
| Ingredient: | bumetanide |
| Patents: | 0 |
Pharmacology for NDA: 215362
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 215362
Suppliers and Packaging for NDA: 215362
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BUMETANIDE | bumetanide | TABLET;ORAL | 215362 | ANDA | Novadoz Pharmaceuticals LLC | 72205-056 | 72205-056-91 | 100 TABLET in 1 BOTTLE (72205-056-91) |
| BUMETANIDE | bumetanide | TABLET;ORAL | 215362 | ANDA | Novadoz Pharmaceuticals LLC | 72205-057 | 72205-057-05 | 500 TABLET in 1 BOTTLE (72205-057-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Feb 5, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Feb 5, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Feb 5, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
